Litcius/Paper detail

Membrane-destabilizing ionizable phospholipids: Novel components for organ-selective mRNA delivery and CRISPR–Cas gene editing

Ning Meng, Dirk Grimm

2021Signal Transduction and Targeted Therapy31 citationsDOIOpen Access PDF

Abstract

In a new study published in Nature Materials , Liu et al. 1 report a novel design of lipid nanoparticles (LNPs) in which multi-tailed ionizable phospholipids (iPhos) constitute the active component, and which facilitates endosomal escape and thus improves delivery of mRNA and/or single-guide (sg)RNA for in vivo gene editing. LNPs composed of the best-performing iPhos and different helper lipids—zwitterionic lipids, ionizable cationic lipids and permanently cationic lipids—achieved selective organ targeting (SORT) and organ-specific CRISPR-Cas9 gene editing in spleen, liver, and lungs of mice, respectively. 1

Topics & Concepts

CRISPRGenome editingMessenger RNAGeneGene deliveryComputational biologyGenetic enhancementChemistryBiologyCell biologyBiochemistryRNA Interference and Gene DeliveryCRISPR and Genetic EngineeringAdvanced biosensing and bioanalysis techniques
Membrane-destabilizing ionizable phospholipids: Novel components for organ-selective mRNA delivery and CRISPR–Cas gene editing | Litcius